2. Hill N.R., Fatoba S.T., Oke J.L., et al. Global prevalence of chronic kidney disease–a systematic review and meta-analysis. PLoS ONE. 2016;11(7):e0158765.

3. Foreman K.J., Marquez N., Dolgert A., et al. Forecasting life expectancy, years of life lost, and all-cause and cause-specific mortality for 250 causes of death: reference and alternative scenarios for 2016–40 for 195 countries and territories. Lancet. 2018;392(10159):2052–90. Doi: 10.1016/S0140- 6736(18)31694-5.

4. Фадин Д.В., Федин В.А., Зингерман Б.В. и др. Результаты 5-летнего опыта тестирования лабораторией ИНВИТРО скорости клубочковой фильтрации на территории РФ. Клиническая нефрология. 2021;2:20–26. Doi.10.18565/nephrology.2021.2.27-33.

5. Томилина Н.А., Волгина Г.В., Бикбов Б.Т. Хроническая болезнь почек. Избранные главы нефрологии. М., 2017. С. 245–47.

6. Pupim L.B., Ikizler T.A. Uremic malnutrition: new insights into an old problem: review. Semin. Dial. 2003;16(3):224–32. Doi: 10.1046/j.1525- 139x.2003.16046.x.

7. Evans W.J., Morley J.E., Argilés J., et al. Cachexia: a new definition. Clin. Nutr. Edinb. Scotl. 2008;27:793–99. Doi: 10.1016/j.clnu.2008.06.013.

8. Fouque D., Kalantar-Zadeh K., Kopple J., et al. A proposed nomenclature and diagnostic criteria for protein-energy wasting in acute and chronic kidney disease. Kidney Int. 2008;73:391–98 Doi: 10.1038/sj.ki.5002585.

9. Ветчинникова О.Н., Пичугина И.С. Белково-энергетическая недостаточность у больных на перитонеальном диализе: факторы риска развития и диагностика. Клиническая нефрология. 2015;1:55–63.

10. Dong J., Wang T., Wang H.Y. The impact of new co-morbidities on nutritional status in continuous ambulatory peritoneal dialysis patients. Blood Purif. 2006;24(5–6):517–23. Doi: 10.1159/000096472.

11. Scialla J.J., Appel L.J., Astor B.C., et al. Estimated net endogenous acid production and serum bicarbonate in African Americans with chronic kidney disease. Clin. J. Am. Soc. Nephrol. 2011;6:1526–32. Doi: 10.2215/ CJN.00150111.

12. Morley J.E. Anorexia of aging: physiologic and pathologic. Am. J. Clin. Nutrit. 1997;66:760–73. Doi: 10.1093/ajcn/66.4.760.

13. Schürch M.A., Rizzoli R., Slosman D., et al. Protein supplements increase serum insulinlike growth factor-i levels and attenuate proximal femur bone loss in patients with recent hip fracture. a randomized, double-blind, placebo-controlled trial. Ann. Intern. Med. 1998;128:801–9. Doi: 10.7326/0003-4819- 128-10-199805150-00002.

14. Levine M.E., Suarez J.A., Brandhorst S., et al. Low protein intake is associated with a major reduction in IGF-1, cancer, and overall mortality in the 65 and younger but not older population. Cell. Metab. 2014;19(3):407–17. Doi: 10.1016/j.cmet.2014.02.006.

15. Cheema B., Abas H., Smith B., et al. Investigation of skeletal muscle quantity and quality in end-stage renal disease. Nephrol. 2010;15(4):454–63. Doi: 10.1111/j.1440-1797.2009. 01261.x.

16. Яковенко А.А., Румянцев А.Ш. Распространенность белково-энергетической недостаточности у пациентов, получающих лечение программным гемодиализом. Нефрология и диализ. 2019;21(1):66–71. Doi: 10.28996.

17. Shu Х., Lin Т., Wang Н., et al. Diagnosis, prevalence, and mortality of sarcopenia in dialysis patients: a systematic review and meta-analysis. J. Cachex. Sarcopen. Muscle. 2022;13:145–58. Doi: 10.1002/jcsm.12890.

18. Ikizler T.A., Burrowes J.D., Byham-Gray L.D., et al. KDOQI Clinical Practice Guideline for Nutrition in CKD: 2020 Update. Am. J. Kidney Dis. 2020;76:S1– 107. Doi: 10.1053/j.ajkd.2020.05.006.

19. Ku E., Kopple J.D., Johansen K.L., et al. Longitudinal weight change during CKD progression and its association with subsequent mortality. Am. J. Kidney Dis. 2017;71(5):657–6. Doi: 10.1053/j.ajkd.2017.09.015.

20. Robinson B.M., Zhang J., Morgenstern H., et al. Worldwide, mortality risk is high soon after initiation of hemodialysis. Kidney Int. 2014;85(1):158–65. Doi: 10.1038/ki.2013.252.

21. Thijssen S., Wong M.M., Usvyat L.A., et al. Nutritional competence and resilience among hemodialysis patients in the setting of dialysis initiation and hospitalization. Clin. J. Am. Soc. Nephrol. 2015;10(9):1593–603. Doi: 10.2215/CJN.08430814.

22. Blumberg B.S., Barnea Z., Cernes R., et al. Association of nutrition status at dialysis start with long-term survival: a 10-year retrospective study. J. Renal Nutrit. 2022;32(6):758–65. Doi: 10.1053/j.jrn.2022.01.001.

23. Qin A., Tan J., Hu W., et al. Oral energy supplementation improves nutritional status in hemodialysis patients with protein–energy wasting: A pilot study. Front. Pharmacol. 2022;13:839803. Doi: 10.3389/fphar.2022.839803.

24. Guo Y., Zhang M., Ye T., et al. Non-protein energy supplement for malnutrition treatment in patients with chronic kidney disease. Asia Pac. J. Clin. Nutr. 2022;31(3):504–11. Doi: 10.6133/apjcn.202209_31(3).0017.

25. Wu H.L., Sung J.M., Kao M.D., et al. Nonprotein calorie supplement improves adherence to low-protein diet and exerts beneficial responses on renal function in chronic kidney disease. J. Ren. Nutr. 2013;23:271–76. Doi: 10.1053/j. jrn.2012.09.003.

26. Małgorzewicz S., Rutkowski P., Jankowska V.M., et al. Effects of renal-specific oral supplementation in malnourished hemodialysis patients. J. Ren. Nutrit. 2011;21(4):347–53. Doi: 10.1053/j.jrn.2010.07.001.

27. Wong M.M.Y., Zheng Y., Renouf D., et al. Trajectories of Nutritional Parameters Before and After Prescribed Oral Nutritional Supplements: A Longitudinal Cohort Study of Patients With Chronic Kidney Disease Not Requiring Dialysis. Canad. J. Kidney Health Dis. 2022;9:1–9. Doi: 10.1177/20543581211069008.

28. Turkmen K., Guney I., Yerlikaya F.H., Tonbul H.Z. The relationship between neutrophil-to-lymphocyte ratio and inflammation in end-stage renal disease patients. Ren. Fail. 2012;34(2):155–9. Doi: 10.3109/0886022X.2011.641514.

29. Fotiadou E., Georgianos P.I., Chourdakis M., et al. Eating during the Hemodialysis Session: A practice improving nutritional status or a risk factor for intradialytic hypotension and reduced dialysis adequacy? Nutrients. 2020;12:1703. Doi: 10.3390/nu12061703.

30. Mah J.Y., Choy S.W., Roberts M.A., et al. Oral protein-based supplements versus placebo or no treatment for people with chronic kidney disease requiring dialysis. Cochrane Database Syst. Rev. 2020;5:CD012616. Doi: 10.1002/14651858.

31. 31. Noor H., Reid J., Slee A. Resistance exercise and nutritional interventions for augmenting sarcopenia outcomes in chronic kidney disease: a narrative review. J. Cachex. Sarcopen. Muscl. 2021;12:1621–40. Doi: 10.1002/ jcsm.12791.

32. Cheu C., Pearson J., Dahlerus C., et al. Association between oral nutritional supplementation and clinical outcomes among patients with ESRD. Clin. J. Am. Soc. Nephrol. 2013;8(1):100–7. Doi: 10.2215/CJN.13091211.

33. Lacson E., Wang W., Zebrowski B., et al. Outcomes associated with intradialytic oral nutritional supplements in patients undergoing maintenance hemodialysis: a quality improvement report. Am. J. Kidney Dis. 2012;60(4):591–600. Doi: 10.1053/j.ajkd.2012.04.019.

34. Suryantoro S.D., Ardhany R.A., Basoeki W., et al. Dietary management of haemodialysis patients with chronic kidney disease and malnourishment. Asia Pac. J. Clin. Nutr. 2021;30(4):579–87. Doi: 10.6133/ apjcn.202112_30(4).0004.

35. Cano N.J., Fouque D., Roth H., et al. Intradialytic parenteral nutrition does not improve survival in malnourished hemodialysis patients: a 2-year multicenter, prospective, randomized study. J. Am. Soc. Nephrol. 2007;18(9):2583–91. Doi: 10.1681/ASN.2007020184.

36. Cano N. Nutritional supplementation in adult patients on hemodialysis. J. Ren. Nutr. 2007;17(1):103–5. Doi: 10.1053/j.jrn.2006.10.018.

37. Sarav V., Friedman A.N. Use of intradialytic parenteral nutrition in patients undergoing hemodialysis. Nutr. Clin. Pract. 2018;33(6):767–71. Doi: 10.1002/ncp.10190.

38. Rhodes C. Enteral Nutrition in Adults with Chronic Kidney Disease: Things to Consider. J. Ren. Nutrit. 2021;31(4):427–30. Doi:10.1053/j.jrn.2021.02.008.

39. 39. Kittiskulnam P., Banjongjit A., Metta К., et al. The benefcial efects of intradialytic parenteral nutrition in hemodialysis patients with protein energy wasting: a prospective randomized controlled trial. Sci. Rep. 2022;2:4529. Doi: 10.1038/s41598-022-08726-8.

40. Li F.K., Chan L.Y.Y., Woo J.C.Y., et al. A 3-year, prospective, randomized, controlled study on amino acid dialysate in patients on CAPD. Am. J. Kidney Dis. 2003;42(1):173–83. Doi: 10.1016/s0272-6386(03)00421-9.

41. Tjiong H.L., van den Berg J.W., Wattimena J.L., et al. Dialysate as Food: combined Amino Acid and Glucose Dialysate Improves Protein Anabolism in Renal Failure Patients on Automated Peritoneal Dialysis. J. Am. Soc. Nephrol. 2005;16(5):1486. Doi: 10.1681/ASN.2004050402.

42. Tjiong H.L., Rietveld T., Wattimena J.L., et al. Peritoneal Dialysis with Solutions Containing Amino Acids Plus Glucose Promotes Protein Synthesis during Oral Feeding. Clin. J. Am. Soc. Nephrol. 2007;2(1):74. Doi: 10.2215/ CJN.01370406.

43. Dombros N., Dratwa M., Feriani M., et al. European best practice guidelines for peritoneal dialysis. 5 Peritoneal dialysis solutions. Nephrol. Dial. Transplantat. 2005;20(Suppl. 9):ix16–20. Doi: 10.1093/ndt/gfi1119.

44. Lochmann H. The benefits of fiber in chronic kidney. J. Ren. Nutrit. 2022;32(6):e1–4. Doi: 10.1053/j.jrn.2022.07.001.

45. Ikee R., Yano K., Tsuru T. Constipation in chronic kidney disease: it is time to reconsider. Ren. Replacem. Ther. 2019;5:51. Doi: 10.1186/s41100-019- 0246-3.

46. Yong K., Mori T., Chew G., et al. The effects of OMEGA-3 fatty acid supplementation upon interleukin-12 and interleukin-18 in chronic kidney disease patients. J. Ren. Nutrit. 2019;29(5):377–85. Doi: 10.1053/j. jrn.2019.01.001.

47. Marini A.C.B., Motobu R.D., Freitas A.T.V., et al. Short-term creatine supplementation may alleviate the malnutrition-inflammation score and lean body mass loss in hemodialysis patients: a pilot randomized placebo-controlled trial. J. Parenteral Enteral Nutrit. 2019;00:1–8. Doi: 10.1002/jpen.1707.

48. Rossi M., Johnson D.V., Campbell K.L. The Kidney–Gut Axis: Implications for Nutrition Care. J. Ren. Nutrit. 2015;25(5):399–403. Doi: 10.1053/j. jrn.2015.01.017.

49. Есаян А.М., Арутюнов Г.П., Мелихов О.Г. Распространенность хронической болезни почек среди пациентов, обратившихся в учреждения первичной медико-санитарной помощи. Результаты проспективного наблюдательного исследования в 12 регионах России. Клиническая нефрология. 2021;3:6–16.

50. Ягудина Р.И., Серпик В.Г., Абдрашитова Г.Т., Котенко О.Н., Экономическое бремя хронической болезни почек в российской федерации. Фармакоэкономика. Теория и практика. 2014;2(4):34–39.

51. Свидетельство о регистрации RU 77.99.32.004.E.000369.01.17.